The European based specialty pharmaceutical company, Ethypharm, collaborated with Reading Scientific Services Ltd (RSSL) to accelerate the manufacture and batch release of fentanyl injection; one of the critical medicines needed for the treatment of COVID-19 patients.
As a major supplier of essential medicines to the NHS, Ethypharm responded to requests from the Department of Health and Social Care (DHSC) for increased volumes of priority medicines by changing its production schedule to meet this urgent need.
“We took the decision to dedicate production at our Romford facility to COVID-19…
Leaders in chemistry data management combine to deliver unified data resource for materials characterisation.
Two of the largest chemical data repositories have announced a new partnership which will allow greater utility and insights in the development of new drugs and materials.
The International Centre for Diffraction Data, ICDD, publishes the PDF® (Powder Diffraction File) and has managed the curation, publication and distribution of X-ray powder diffraction data for 75 years. The Cambridge Crystallographic Data Centre, CCDC, curates and maintains the CSD (Cambridge Structural…
Conducted over 26 – 27 May 2020 as many countries around the world commenced publication of the plans to emerge from Covid-19 lock-down restrictions, including in terms of travel, One Nucleus surveyed a cross section of its members to ascertain their views on how and when their staff would resume business travel.
The questions sought to assess the appetite for engaging in business travel following absence of travel and reliance on remote meetings via eg video conferencing. Furthermore, we also asked what they perceived to be the challenges to them and colleagues resuming business…
An experienced public and private company Non-Executive Director, Peter has sat on over 30 boards during his career. He is currently a Non-Executive Director of Endomagnetics Ltd, a company improving cancer surgery outcomes; and the medical charity LifeArc which has assets significantly in excess of £1bn following the monetisation of the leading cancer drug Keytruda. Recent Directorships include SpringWorks Therapeutics Inc, a rare disease company that successfully listed on NASDAQ in September 2019, the Biotechnology Growth Trust plc, a £400m investment trust investing in global…
Recently, Santander’s John Carroll hosted our COVID-19 Webinar Series on digital health. Joined by sector and trade experts Timothy Johns MBA, Head of Digital Health at the Department for International Trade (DIT), Intralink’s Graham Barker and ChongYoon Kwon, Industrial Bank of Korea. They discussed what they’d learnt from the pandemic and the opportunities emerging for UK digital health companies. To listen go to: http://ms.spr.ly/6047T90Dv
As businesses look ahead to evolve their operations, Santander UK recently hosted a life science sector webinar with our partner, British Centres for Business - BCB UAE to look at the opportunities in the UAE and the acceleration of digital health in the region.
We were joined by Jeffrey Kemprecos (GSK), Andrea Tithecott, Hisham Qaryouti, Kostantin Cachia and Joe Hepworth to discuss the life science opportunity in the UAE and how to navigate the regulatory landscape to help you successfully launch your product or service in the region. To join visit http://ms.spr.ly/6043TiFEW
The downside of working with many C Suite Executives is that I also get to see the effects that stress and burnout can take on people.
In 2019, the World Health Organisation (WHO) recognised burnout as a chronic medical condition, and with over 60% of board-level executives reporting feelings of high anxiety and stress on a regular basis, burnout in the C Suite is of growing concern. These are people who are at the heart of the business, and without them functioning at the best of their ability, potentially every employee working for them will suffer either directly or indirectly.
In…
TWO businesses based in The Biosphere on Newcastle Helix have been awarded funding to accelerate their innovations to support the global fight against the COVID-19.
Innovate UK, the UK’s innovation agency has awarded ExplantLab and Atelerix almost £50,000 each to fast track their ideas and research. Both are based in The Biosphere and were among only 800 applicants chosen to receive a share of £40million government investment out of a record 8,600 applications from across the UK.
Managed by Innovate UK, the Fast Start competition was launched in April to fast-track the development of…
Cambridge, UK, 2nd June 2020 / Following the retirement of Tony Brampton, Eddy Littler has been appointed as non-executive Chairman of Domainex Ltd.
Eddy began his research career at the University of Leeds obtaining his PhD in virology. After postdoctoral research at McMaster University in Canada, he joined the Paterson Institute for Cancer Research in Manchester. Eddy held senior positions with Wellcome Research Laboratories, GSK and Medivir, where he led the team that discovered Olysio which was a major drug for treatment of hepatitis C virus. Eddy became CEO of Domainex in May 2008 and…
Biocair, a global specialist in life sciences logistics, was selected to transport time-critical plasmids from the USA to the Africa Health Research Institute (AHRI) in Durban, South Africa.
AHRI Faculty Member and Research Group Leader at the Max Planck Institute for Infection Biology in Berlin, Dr Alex Sigal, highlighted the importance of the materials being transported and the standard of service provided by Biocair:
“These reagents that Biocair delivered to us from the USA, at record speed and surmounting considerable obstacles because of the lockdown both in the USA and in South Africa…